$BIIB Recent Headlines Biogen Idec investors foc
Post# of 94265
Posted On: 01/31/2014 3:26:17 PM
$BIIB Recent Headlines
Biogen Idec investors focus on positive, ignore outlook for 2014 2:02 p.m. Jan. 29, 2014 - blogs.marketwatch.com
Biogen profit jumps on MS treatment revenue 7:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 8:00 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
The Four Horsemen send a message 12:46 p.m. Nov. 13, 2013 - The Trading Deck
Biotech Sector Performance January 2014 Strong, but What's Ailing Celgene? 2:12 p.m. Today - TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. Today - Zacks.com
Facebook Tops 5 Leaders With Rising Profit Estimates 8:00 a.m. Today - Investors Business Daily
Jefferies Says Buy Any Pullback on Top Focus Stocks for Big Gains 7:22 a.m. Today - 247WallSt.com
Biogen Idec Is a Buy Idea 12:09 a.m. Today - Barrons.com
Celgene -2.2% after earnings, NEJM report, while other big biotechs surge 2:44 p.m. Jan. 30, 2014 - Seeking Alpha
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 30, 2014 - Zacks.com
FDA Nod for New Formulation of Teva's Copaxone - Analyst Blog 5:10 p.m. Jan. 29, 2014 - Zacks.com
Biogen's Report Sends Stock Up; Other Biotechs Follow 5:01 p.m. Jan. 29, 2014 - Investors Business Daily
Will Affymetrix (AFFX) Surprise This Earnings Season? - Analyst Blog 4:30 p.m. Jan. 29, 2014 - Zacks.com
Biogen Beats, Tecfidera Continues to Shine - Analyst Blog 1:32 p.m. Jan. 29, 2014 - Zacks.com
Biogen Idec Management Discusses Q4 2013 Results - Earnings Call Transcript 12:50 p.m. Jan. 29, 2014 - Seeking Alpha
Why Caution Is Prevailing in Biotechs Into and After Earnings 11:29 a.m. Jan. 29, 2014 - 247WallSt.com
New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN) 10:44 a.m. Jan. 29, 2014 - benzinga.com
Biogen MS Drug Tecfidera Outperforms; Outlook Light 10:41 a.m. Jan. 29, 2014 - Investors Business Daily
Top Trending Tickers On StockTwits For January 29 8:51 a.m. Jan. 29, 2014 - benzinga.com
An Option On Adoption Of A New Multiple Sclerosis Treatment 8:51 a.m. Jan. 29, 2014 - Seeking Alpha
Biogen profit powers higher on strong sales for MS treatment 8:14 a.m. Jan. 29, 2014 - Seeking Alpha
The Best of the Best Picks of the Credit Suisse Top 50 Stocks 8:09 a.m. Jan. 29, 2014 - 247WallSt.com
Facebook, Biogen, Sands Among Top Big Caps Reporting 7:02 a.m. Jan. 29, 2014 - Investors Business Daily
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia 1:00 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion 6:30 a.m. Jan. 29, 2014 - BusinessWire - BZX
RBCC Develops Innovations in White-Hot 3D Bioprinting Sector 4:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver 9:31 a.m. Jan. 24, 2014 - PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 9:10 a.m. Jan. 13, 2014 - PR Newswire - PRF
RBCC Partner n3D Commercializes New 3D Bioprinting Technology 5:53 a.m. Jan. 13, 2014 - BusinessWire - BZX
Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies 7:10 a.m. Jan. 9, 2014 - PR Newswire
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies 7:00 a.m. Jan. 9, 2014 - PR Newswire
Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs 6:59 a.m. Jan. 9, 2014 - GlobeNewswire
Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:29 p.m. Jan. 7, 2014 - BusinessWire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
Biogen Idec investors focus on positive, ignore outlook for 2014 2:02 p.m. Jan. 29, 2014 - blogs.marketwatch.com
Biogen profit jumps on MS treatment revenue 7:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 8:00 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
The Four Horsemen send a message 12:46 p.m. Nov. 13, 2013 - The Trading Deck
Biotech Sector Performance January 2014 Strong, but What's Ailing Celgene? 2:12 p.m. Today - TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. Today - Zacks.com
Facebook Tops 5 Leaders With Rising Profit Estimates 8:00 a.m. Today - Investors Business Daily
Jefferies Says Buy Any Pullback on Top Focus Stocks for Big Gains 7:22 a.m. Today - 247WallSt.com
Biogen Idec Is a Buy Idea 12:09 a.m. Today - Barrons.com
Celgene -2.2% after earnings, NEJM report, while other big biotechs surge 2:44 p.m. Jan. 30, 2014 - Seeking Alpha
Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 30, 2014 - Zacks.com
FDA Nod for New Formulation of Teva's Copaxone - Analyst Blog 5:10 p.m. Jan. 29, 2014 - Zacks.com
Biogen's Report Sends Stock Up; Other Biotechs Follow 5:01 p.m. Jan. 29, 2014 - Investors Business Daily
Will Affymetrix (AFFX) Surprise This Earnings Season? - Analyst Blog 4:30 p.m. Jan. 29, 2014 - Zacks.com
Biogen Beats, Tecfidera Continues to Shine - Analyst Blog 1:32 p.m. Jan. 29, 2014 - Zacks.com
Biogen Idec Management Discusses Q4 2013 Results - Earnings Call Transcript 12:50 p.m. Jan. 29, 2014 - Seeking Alpha
Why Caution Is Prevailing in Biotechs Into and After Earnings 11:29 a.m. Jan. 29, 2014 - 247WallSt.com
New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN) 10:44 a.m. Jan. 29, 2014 - benzinga.com
Biogen MS Drug Tecfidera Outperforms; Outlook Light 10:41 a.m. Jan. 29, 2014 - Investors Business Daily
Top Trending Tickers On StockTwits For January 29 8:51 a.m. Jan. 29, 2014 - benzinga.com
An Option On Adoption Of A New Multiple Sclerosis Treatment 8:51 a.m. Jan. 29, 2014 - Seeking Alpha
Biogen profit powers higher on strong sales for MS treatment 8:14 a.m. Jan. 29, 2014 - Seeking Alpha
The Best of the Best Picks of the Credit Suisse Top 50 Stocks 8:09 a.m. Jan. 29, 2014 - 247WallSt.com
Facebook, Biogen, Sands Among Top Big Caps Reporting 7:02 a.m. Jan. 29, 2014 - Investors Business Daily
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia 1:00 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion 6:30 a.m. Jan. 29, 2014 - BusinessWire - BZX
RBCC Develops Innovations in White-Hot 3D Bioprinting Sector 4:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver 9:31 a.m. Jan. 24, 2014 - PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 9:10 a.m. Jan. 13, 2014 - PR Newswire - PRF
RBCC Partner n3D Commercializes New 3D Bioprinting Technology 5:53 a.m. Jan. 13, 2014 - BusinessWire - BZX
Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies 7:10 a.m. Jan. 9, 2014 - PR Newswire
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies 7:00 a.m. Jan. 9, 2014 - PR Newswire
Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs 6:59 a.m. Jan. 9, 2014 - GlobeNewswire
Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:29 p.m. Jan. 7, 2014 - BusinessWire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
(0)
(0)